Short Title:
VIIP Pharm
Responsible HRP Element:
Human Health Countermeasures
Funding Status:
Completed - Task completed and produced a deliverable
|
Procurement Mechanism(s):
|
|
Aims:
To determine if affected crewmembers use medications known to be associated with cardiovascular, visual changes and ICP elevations in terrestrial medical practice and to assess the likelihood of medications as causal agents in spaceflight-associated visual changes and ICP elevation by using a large terrestrial database to model correlations.
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
A final report quantifying the health risk, including confirmation or elimination of medications as contributing or causal factors in the vision changes and elevated intracranial pressure seen during and after spaceflight.
Internal Customers:
Human Health Countermeasures
External Customers:
None